125 related articles for article (PubMed ID: 16998464)
21. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine carcinoma of uterine cervix.
Kajiwara H; Hirabayashi K; Miyazawa M; Nakamura N; Hirasawa T; Muramatsu T; Mikami M; Yasuda M; Osamura RY
Arch Gynecol Obstet; 2009 Apr; 279(4):521-5. PubMed ID: 18726606
[TBL] [Abstract][Full Text] [Related]
22. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases.
Wang TY; Chen BF; Yang YC; Chen H; Wang Y; Cviko A; Quade BJ; Sun D; Yang A; McKeon FD; Crum CP
Hum Pathol; 2001 May; 32(5):479-86. PubMed ID: 11381365
[TBL] [Abstract][Full Text] [Related]
23. Hep Par 1 expression in carcinoma of the cervix: implications for diagnosis and prognosis.
Thamboo TP; Wee A
J Clin Pathol; 2004 Jan; 57(1):48-53. PubMed ID: 14693835
[TBL] [Abstract][Full Text] [Related]
24. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study.
Sitthinamsuwan P; Angkathunyakul N; Chuangsuwanich T; Inthasorn P
J Med Assoc Thai; 2013 Jan; 96(1):83-90. PubMed ID: 23720983
[TBL] [Abstract][Full Text] [Related]
25. Small cell neuroendocrine carcinomas of the lung do not harbor high-risk human papillomavirus.
Hartley CP; Steinmetz HB; Memoli VA; Tafe LJ
Hum Pathol; 2015 Apr; 46(4):577-82. PubMed ID: 25661244
[TBL] [Abstract][Full Text] [Related]
26. CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis.
Zhang J; Chang B; Liu J
Hum Pathol; 2013 Sep; 44(9):1882-9. PubMed ID: 23664487
[TBL] [Abstract][Full Text] [Related]
27. Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors.
Afify AM; Tate S; Durbin-Johnson B; Rocke DM; Konia T
Int J Biol Markers; 2011; 26(1):50-7. PubMed ID: 21279958
[TBL] [Abstract][Full Text] [Related]
28. Alternation of β-catenin and CD44s Immunoexpression in Different Histopathological Grades of Oral Squamous Cell Carcinoma.
Zargaran M
Asian Pac J Cancer Prev; 2020 May; 21(5):1181-1185. PubMed ID: 32458620
[TBL] [Abstract][Full Text] [Related]
29. Neuroendocrine differentiation in cervical carcinoma.
Savargaonkar PR; Hale RJ; Mutton A; Manning V; Buckley CH
J Clin Pathol; 1996 Feb; 49(2):139-41. PubMed ID: 8655680
[TBL] [Abstract][Full Text] [Related]
30. CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer.
Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T
Eur J Cancer; 1998 Dec; 34(13):2107-11. PubMed ID: 10070319
[TBL] [Abstract][Full Text] [Related]
31. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
Chang A; Amin A; Gabrielson E; Illei P; Roden RB; Sharma R; Epstein JI
Am J Surg Pathol; 2012 Oct; 36(10):1472-6. PubMed ID: 22982890
[TBL] [Abstract][Full Text] [Related]
32. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
33. Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.
Heeren AM; Punt S; Bleeker MC; Gaarenstroom KN; van der Velden J; Kenter GG; de Gruijl TD; Jordanova ES
Mod Pathol; 2016 Jul; 29(7):753-63. PubMed ID: 27056074
[TBL] [Abstract][Full Text] [Related]
34. Expression of osteopontin and CD44 molecule in papillary renal cell tumors.
Matusan K; Dordevic G; Mozetic V; Lucin K
Pathol Oncol Res; 2005; 11(2):108-13. PubMed ID: 15999156
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis Phenomena in Squamous Cell Carcinomas and Adenocarcinomas of the Uterine Cervix.
Eduardo MG; Campaner AB; Silva MA
Pathol Oncol Res; 2015 Sep; 21(4):887-92. PubMed ID: 25682239
[TBL] [Abstract][Full Text] [Related]
36. Expression of cadherins, p53, and BCL2 in small cell carcinomas of the cervix: potential tumor suppressor role for N-cadherin.
Zarka TA; Han AC; Edelson MI; Rosenblum NG
Int J Gynecol Cancer; 2003; 13(2):240-3. PubMed ID: 12657131
[TBL] [Abstract][Full Text] [Related]
37. nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Lee CS; Gad J
Pathol Int; 1998 Oct; 48(10):806-11. PubMed ID: 9788265
[TBL] [Abstract][Full Text] [Related]
38. Expression and clinical significance of a new neuroendocrine marker secretagogin in cervical neuroendocrine carcinoma.
Yu L; Suye S; Huang R; Liang Q; Fu C
J Clin Pathol; 2021 Dec; 74(12):787-795. PubMed ID: 33060116
[TBL] [Abstract][Full Text] [Related]
39. Large cell neuroendocrine carcinoma of the uterine cervix exhibiting TTF1 immunoreactivity.
McCluggage WG; Sargent A; Bailey A; Wilson GE
Histopathology; 2007 Sep; 51(3):405-7. PubMed ID: 17727482
[No Abstract] [Full Text] [Related]
40. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
